| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8733752 | Critical Reviews in Oncology/Hematology | 2017 | 7 Pages |
Abstract
ERCC1 positivity might be a prognostic indicator for poorer survival outcomes among patients with AUC. ERCC1 positivity was trending to poorer OS but was statistically worse for PFS. Further large prospective studies are warranted as ERCC1 could be used as a predictive marker to direct treatment of patients with AUC.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Yuksel Urun, Jeffrey J. Leow, Andre P. Fay, Laurence Albiges, Toni K. Choueiri, Joaquim Bellmunt,